A non-invasive approach to explore the discriminatory potential of the urinary volatilome of invasive ductal carcinoma of the breast

Taunk, K; Taware, R; More, TH; Porto-Figueira, P; Pereira, JAM; Mohapatra, R; Soneji, D; Camara, JS; Nagarajaram, HA; Rapole, S

HERO ID

4729668

Reference Type

Journal Article

Year

2018

HERO ID 4729668
In Press No
Year 2018
Title A non-invasive approach to explore the discriminatory potential of the urinary volatilome of invasive ductal carcinoma of the breast
Authors Taunk, K; Taware, R; More, TH; Porto-Figueira, P; Pereira, JAM; Mohapatra, R; Soneji, D; Camara, JS; Nagarajaram, HA; Rapole, S
Journal RSC Advances
Volume 8
Issue 44
Page Numbers 25040-25050
Abstract Worldwide, breast invasive ductal carcinoma (IDC) accounts for the majority of the reported cases of this form of cancer. IDC effective management, as for any form of cancer, would greatly benefit from early diagnosis. This, however, due to various socio-economic reasons, is very far for the reality in developing countries like India, where cancer diagnosis is often carried out at late stages when disease management is troublesome. With the present work, we aim to evaluate a simple analytical methodology to identify a set of volatile organic compounds (VOCs) in urine samples, as a biosignature for IDC. Using solid-phase microextraction followed by gas chromatography/mass spectrometry, a panel of 14 urinary VOCs was found to discriminate IDC (n = 65) from a healthy control (HC) group (n = 70) through multivariate statistical treatments. Furthermore, metabolic pathway analysis revealed various dysregulated pathways involved in IDC patients hinting that their detailed investigations could lead to novel mechanistic insights into the disease pathophysiology. In addition, we validated the expression pattern of five of these VOCs namely 2-ethyl-1-hexanol, isolongifolenone, furan, dodecanoic acid, 2-methoxy-phenol in another external cohort of 59 urinary samples (IDC = 32 and HC = 27) and found their expression pattern to be consistent with the primary sample set. To our knowledge, this is the first study exploring breast IDC volatome alterations in Indian patients.
Doi 10.1039/c8ra02083c
Wosid WOS:000438939300041
Is Certified Translation No
Dupe Override No
Is Public Yes